The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer
Estrogens have been implicated in the pathogenesis of various cancers, with increasing concern regarding the overall rising incidence of disease and exposure to environmental estrogens. Estrogens, both endogenous and environmental, manifest their actions through intracellular and plasma membrane rec...
Main Authors: | Keith A. Hall, Edward J. Filardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/20/2460 |
Similar Items
-
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
by: Rainer Girgert, et al.
Published: (2019-01-01) -
Peering into the Brain’s Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders
by: Shokouh Arjmand, et al.
Published: (2023-09-01) -
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function
by: Milad Rouhimoghadam, et al.
Published: (2020-11-01) -
Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
by: Alexandre Acramel, et al.
Published: (2022-06-01) -
Estrogen receptor subtype mediated anti-inflammation and vasorelaxation via genomic and nongenomic actions in septic mice
by: Luyun Zhang, et al.
Published: (2023-05-01)